Enhancement of Th1 immune response by CD8α+ dendritic cells loaded with heat shock proteins enriched tumor extract in tumor-bearing mice

Cellular Immunology

Volumn 260, Issue 1, 2009, Pages 28-32

  Azadmehr, Abbas ^a   Pourfathollah, Ali Akbar ^a   Amirghofran, Zahra ^b   Hassan, Zuhair Mohammad ^a   Moazzeni, Seyed Mohammad ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CD8 + dendritic cells; Heat shock protein; Th1 response; Tumor extract

Indexed keywords

CD8ALPHA ANTIGEN; DENDRITIC CELL VACCINE; GAMMA INTERFERON; HEAT SHOCK PROTEIN 70; INTERLEUKIN 5; TUMOR EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; FEMALE; FIBROSARCOMA; IMMUNE RESPONSE; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SURVIVAL TIME; TH1 CELL; TUMOR REGRESSION;

ANIMALS; ANTIGENS, CD8; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CANCER VACCINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSARCOMA; HOT TEMPERATURE; HSP70 HEAT-SHOCK PROTEINS; IMMUNOTHERAPY; INTERFERON-GAMMA; INTERLEUKIN-5; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; TH1 CELLS;

ANIMALIA; MUS;

EID: 70350414527     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2009.07.003     Document Type: Article

References (33)

1. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., and Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18 (2000) 767-811
2. Mellman I., and Steinman R.M. Dendritic cells: specialized and regulated antigen processing machines. Cell 106 (2001) 255-258
3. Brossart P., Goldrath A.W., Butz E.A., Martin S., and Bevan M.J. Virus mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J. Immunol. 158 (1997) 3270-3276
4. Shen Z., Reznikoff G., Dranoff G., and Rock K.L. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158 (1997) 2723-2730
5. Kao J.Y., Zhang M., Chen C.M., and Chen J.J. Superior efficacy of dendritic cell-tumor fusion vaccine compared with tumor lysate-pulsed dendritic cell vaccine in colon cancer. Immunol. Lett. 101 (2005) 154-159
6. Shortman K., and Caux C. Dendritic cell development: multiple pathways to nature's adjuvants. Stem Cells 15 (1997) 409-419
7. Vremec D., Pooley J., Hochrein H., Wu L., and Shortman K. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164 (2000) 2978-2986
8. Ikeda H., Chamoto K., Tsuji T., Suzuki Y., Wakita D., Takeshima T., and Nishimura T. The critical role of type-1 innate and acquired immunity in tumor immunotherapy. Cancer Sci. 95 (2004) 697-703
9. - dendritic cell activation status plays an integral role in influencing Th2 response development. J. Immunol. 167 (2001) 1982-1988
10. Maldonado-Lopez R., Maliszewski C., Urbain J., and Moser M. Cytokines regulate the capacity of CD8alpha (+) and CD8alpha (-) dendritic cells to prime Th1/Th2 cells in vivo. J. Immunol. 167 (2001) 4345-4350
11. Manickasingham S.P., Edwards A.D., Schulz O., and Reis e Sousa C. The ability of murine dendritic cell subsets to direct T helper cell differentiation is dependent on microbial signals. Eur. J. Immunol. 33 (2003) 101-107
12. Pulendran B., Smith J.L., Caspary G., Brasel K., Pettit D., Maraskovsky E., and Maliszewski C.R. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 96 (1999) 1036-1041
13. Reis e Sousa C., Hieny S., Scharton-Kersten T., Jankovic D., Charest H., Germain R.N., and Sher A. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186 (1997) 1819-1829
14. + lymphoid dendritic cells. J. Exp. Med. 189 (1999) 1981-1986
15. Chang A.E., Redman B.G., Whitfield J.R., Nickoloff B.J., Braun T.M., Lee P.P., Geiger J.D., and Mule J.J. A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer. Clin. Cancer Res. 8 (2002) 1021-1032
16. Yu J.S., Liu G., Ying H., Yong W.H., Black K.L., and Wheeler C.J. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer Res. 64 (2004) 4973-4979
17. Binder R.J., Vatner R., and Srivastava P. The heat-shock protein receptors: some answers and more questions. Tissue Antigens 64 (2004) 442-451
18. Graner M.W., Zeng Y., Feng H., and Katsanis E. Tumor-derived chaperonerich cell lysates are effective therapeutic vaccines against a variety of cancers. Cancer Immunol. Immunother. 52 (2003) 226-234
19. Kim H.S., Choo Y.S., Koo T., Bang S., Oh T.Y., Wen J., and Song S.Y. Enhancement of antitumor immunity of dendritic cells pulsed with heat-treated tumor lysate in murine pancreatic cancer. Immunol. Lett. 103 (2006) 142-148
20. Srivastava P. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu. Rev. Immunol. 20 (2002) 395-425
21. Schnurr M., Galambos P., Scholz C., Then F., Dauer M., Endres S., and Eigler A. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines. Cancer Res. 61 (2001) 6445-6450
22. Whiteside T.L., and Odoux C. Dendritic cell biology and cancer therapy. Cancer Immunol. Immunother. 53 (2004) 240-248
23. Fields R.C., Shimizu K., and Mule J.J. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc. Natl. Acad. Sci. USA 95 (1998) 9482-9487
24. Holtl L., Zelle-Rieser C., Gander H., Papesh C., Ramoner R., Bartsch G., Rogatsch H., Barsoum A.L., Coggin J.H., and Thurnher M. Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells. Clin. Cancer Res. 8 (2002) 3369-3376
25. Maier T., Tun-Kyi A., Tassis A., Jungius K.P., Burg G., Dummer R., and Nestle F.O. Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells. Blood 102 (2003) 2338-2344
26. Rains N., Cannan R.J., Chen W., and Stubbs R.S. Development of a dendritic cell (DC)-based vaccine for patients with advanced colorectal cancer. Hepatogastroenterology 48 (2001) 347-351
27. Reinhard G., Marten A., Kiske S.M., Feil F., Bieber T., and Schmidt-Wolf I.G. Generation of dendritic cell-based vaccines for cancer therapy. Br. J. Cancer 86 (2002) 1529-1533
28. Basu S., Binder R.J., Ramalingam T., and Srivastava P.K. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70 and calreticulin. Immunity 14 (2001) 303-313
29. Becker T., Hartl F.U., and Wieland F. CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J. Cell. Biol. 158 (2002) 1277-1285
30. + subclasses of dendritic cells undergo phenotypic and functional maturation in vitro and in vivo. J. Leukoc. Biol. 69 (2001) 951-958
31. Maroof A., and Kaye P.M. Temporal regulation of interleukin-12p70 (IL-12p70) and IL-12-related cytokines in splenic dendritic cell subsets during Leishmania donovani infection. Infect. Immun. 76 (2008) 239-249
32. - DC. J. Immunol. 177 (2006) 7067-7075
33. + tumor-infiltrating lymphocytes. J. Exp. Med. 173 (1991) 647-658